emodynamic instability with low cardiac output and low to normal filling pressures is frequent in survivors after out-of-hospital cardiac arrest (OHCA), but may not always be apparent at hospital admission. 1 The hemodynamic profile suggestive of myocardial stunning and vasodilation is part of the postcardiac arrest syndrome, characterized by impaired vasoregulation, reduced cardiac output, and hypotension, which all contribute to decreased organ perfusion.
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Methods

Study Design
This study was a prospective, observational study based on 171 patients enrolled at Copenhagen University Hospital Rigshospitalet in the TTM Trial. 7 Patients were randomized in a 1:1 fashion to TTM at 33°C (TTM33) or 36°C (TTM36) for 24 hours after cardiac arrest. In the current study, as in the main trial, investigators were unblinded for temperature allocation, but all analyses of hemodynamics parameters were performed blinded for temperature allocation. Adult patients (aged ≥18 years) resuscitated from OHCA of presumed cardiac cause, who remained unconscious (Glasgow Coma Score <8) after sustained return of spontaneous circulation >20 minutes, were eligible for inclusion. Main exclusion criteria were those listed in TTM Trial article including severe refractory shock defined as sustained systolic blood pressure <80 mm Hg. 7 Prehospital data regarding the cardiac arrest including initial arrhythmia, witnessed arrest, administration of bystander cardiopulmonary resuscitation, and time to return of spontaneous circulation were systematically collected according to Utstein guidelines. 8 The Ethics Committee of the Capital Region Copenhagen approved the main study protocol (H-1-2010-059) including the standard use of pulmonary artery catheter in all patients for research purposes. Written informed consent was obtained from patients' next of kin and general practitioner in all cases and from patients regaining consciousness after cardiac arrest.
Postcardiac Arrest Care and Hemodynamic Measurements
All patients were admitted at the intensive care unit and were sedated, intubated, and mechanically ventilated throughout the intervention period according to the study protocol. 9 Propofol and fentanyl was titrated to achieve a Richmond Agitation-Sedation Scale score of −4; neuromuscular blocking agents were administered to reduce shivering if needed. All patients were actively cooled with the use of a surface cooling device (Thermowrap with Allon unit; MTRE, Israel). Active cooling was initiated immediately after randomization with an induction period of 4 hours to achieve the target temperature, followed by a maintenance period of 24 hours with subsequent active rewarming of no more than 0.5°C per hour to 37°C in both groups.
Emergency coronary angiography, defined as coronary angiography <12 hours after cardiac arrest, was performed in all patients presenting with ST-segment elevations or at the discretion of the treating physician. The general revascularization strategy was percutaneous coronary intervention of culprit lesion. Coronary intervention was defined as successful if it resulted in residual stenosis of <50% and a Thrombolysis in Myocardial Infarction grade 3 flow.
Crystalloid fluids were administered in all patients with general treatment goals of central venous pressure (CVP) of 10 to 15 mm Hg to optimize right heart filling pressure, mean arterial pressure (MAP) ≥65 mm Hg, and urine output >1.5 mL/kg per hour to secure adequate organ perfusion. Data from the serial right heart catheterizations were not used to define treatment goals or optimize the hemodynamic status. Inotropics/vasopressors were used to achieve adequate organ perfusion primary directed by clinical parameters such as MAP, CVP, and urine output to achieve the predefined hemodynamic treatment goals. Standardized vasopressor dosage was described by the cumulative vasopressor index and the cardiovascular subscore of Sequential Organ Failure Assessment (SOFA). 10, 11 Patients' hemodynamics were monitored as soon as possible after intensive care unit admission with an arterial pressure catheter in the radial artery and insertion of a 7.5F triple lumen Swan-Ganz thermistor and balloon-tipped catheter (Edwards Lifesciences, Irvine, CA) with CVP values obtained from the proximal port. Pulmonary capillary wedge pressure, CVP, systolic pulmonary artery pressure, diastolic pulmonary artery pressure, mean pulmonary artery pressure, and cardiac output were measured at the prespecified time points: after insertion of pulmonary artery catheter, at target temperature, 16 hours, 28 hours (24 hours at target temperature), 36 hours (after rewarming) and 48 hours after randomization.
Cardiac output was estimated using the thermodilution technique with infusion of cold isotonic glucose and a temperature gradient of ≤10°C was required. Cardiac output was measured as the average of 3 measurements with ≤10% variance. 12 Interobserver comparison of cardiac output measurements in 13 (8%) patients showed low bias (0.42%; mean difference of 0.02±0.52 L/min; P=0.57) with a standard error of the estimate of 0.26 L/min and good reproducibility with a coefficient of variation of 3% corrected for dependency of duplicate measurements. 13 Cardiac power index was calculated as MAP×cardiac index (CI)/451 W/m 2 . 14 In a consecutive subgroup of the first 130 patients, serial transthoracic echocardiography was available in 119 patients at admission, 28 and 48 hours after randomization using Philips CX50 (Philips Healthcare, Best, The Netherlands) cardiac ultrasound system with the patient in supine position tilted 15° toward left decubitus position to allow for acquisition of apical views. Images were stored digitally for offline analysis using Philips Xcelera analysis software version 3.1 (Philips Healthcare).
Left ventricular (LV) volumes and LV ejection fraction (LVEF) were assessed using the Simpson modified rule from the apical 4-chamber view. Doppler echocardiography assessing mitral inflow with early peak transmitral filling velocity (E) and late peak transmitral filling velocity (A) was performed in the apical 4-chamber view with the pulsed wave Doppler sample volume placed at the tips of mitral leaflets. Mitral annular motion was assessed using pulsed wave tissue Doppler with the sample volume placed in the septal and lateral mitral annulus for the measurements of peak early diastolic (e′) and peak systolic (s′) tissue velocities. The mean of septal and lateral e′ and s′ velocities was reported. Right ventricular longitudinal function was evaluated by tricuspid annular plane systolic excursion. For Doppler recordings, the average of at least 3 consecutive beats was measured. The analyses were performed blinded to allocated treatment and to invasive measurements.
Central mixed venous blood sample and arterial blood were drawn at the previous mentioned time points and analyzed for mixed venous
WHAT IS KNOWN
• Hemodynamic instability is common after cardiac arrest and is a recognized component of the postcardiac arrest syndrome. Targeted temperature management is used in this setting to attenuate brain injury.
• The use of targeted temperature management affects central hemodynamics, but there is limited data that details how different target temperatures may influence metabolism and hemodynamics in the postcardiac arrest syndrome.
WHAT THE STUDY ADDS
• In a randomized study, a lower level of target temperature after cardiac arrest was associated with increased systemic vascular tone, decreased cardiac output because of lower heart rate with unchanged myocardial contractility, and increased levels of lactate compared with a higher actively controlled target temperature.
• These hemodynamic findings may be clinically relevant when choosing the optimal level of target temperature in future patients.
by guest on April 6, 2017 http://circinterventions.ahajournals.org/ Downloaded from oxygen saturation (SVO 2 ), lactate concentration, and pH with the α-stat method according to the TTM protocol. Lactate clearance (percentage) was defined as first lactate measured at intensive care unit admission (hour 0) minus lactate at hour 12, divided by lactate at intensive care unit admission.
Mean infused doses of propofol and fentanyl were reported at the prespecified time points, and cumulative doses of propofol, fentanyl, and boluses of cisatracurium were reported within the first 48 hours.
End Points
The primary end point was systemic vascular resistance index (SVRI) after 24 hours at target temperature. Secondary end points were mean group difference in SVRI, CI, systolic (LVEF, s′) and diastolic function (E/e′), SVO 2 , and lactate levels <48 hours after randomization.
Statistics
The sample size estimate was based on SVR findings from patients undergoing TTM at 33°C compared with normothermia. 5 With a standard deviation of 20%, α=0.05, and β=0.80, a sample size of 100 patients allowed for detecting of a 30% difference in SVR, which was considered clinically significant. To account for dropouts we planned to enroll ≤120 patients. The analyses were performed by the intention-to-treat principles in all patients and supplemented by per-protocol analyzes excluding patients who were rewarmed to 36°C before reaching the intended time point of 28 hours after randomization (TTM33, n=6; TTM36, n=0). Differences in baseline demographic variables were compared using Student t test, χ 2 test, and Wilcoxon rank-sum test, as appropriate. Demographics and hemodynamic variables are presented as mean±SD or proportions (%), and for variables with a non-normal distribution, data are presented as median and lower to upper quartile (Q1-Q3). Between-group differences for continuous hemodynamic and metabolic variables in the study period were evaluated with repeated-measures mixed models with an unstructured covariance structure with TTM group, time point, and the interaction term of TTM group with time, if significant, as fixed effects. Overall differences between TTM groups were reported as β-coefficients and P values, denoted P group . Differences at each time point was assessed by repeated-measures mixed models including the interaction term of TTM group with time if significant or by standard t test and Wilcoxon rank-sum test as appropriate. Spearman correlation coefficients were used to estimate associations between SVO 2 and CI. All tests were 2-sided, and statistical significance was defined as P<0.05 unless other specified. All statistical analyses were performed using the SAS statistical software, version 9.2 (SAS Institute, Cary, NC).
Results
Patient Population
Between November 2010 and January 2013, 171 consecutive screened comatose survivors after OHCA were included in the TTM Trial at Copenhagen University Hospital Rigshospitalet, with 87 patients in the TTM33 group and 84 patients in the TTM36 group ( Figure 1 ). Baseline characteristics are presented in Table 1 . Seven patients died before insertion of a pulmonary catheter, whereas the attending physician decided against inserting the pulmonary catheter in 10 cases: temporary pace wire in the right ventricle (n=3), excessive bleeding (n=2), repetitive induction of ventricular fibrillation during catheter advancement (n=1), and no reason (n=4) regarded as protocol violation, with no differences between TTM groups. Invasive hemodynamic data in patients undergoing a full 24-hour temperature intervention was available in 73 patients in the TTM33 group and 75 patients in the TTM36 group with no differences in baseline characteristics (per-protocol population). Emergency coronary angiography was performed in 128 patients (75%), and the distribution of coronary pathology, rate of percutaneous coronary intervention, and rate of successful percutaneous coronary intervention is presented in Table 2 .
Baseline Hemodynamic Parameters
At randomization, the 2 groups had similar baseline hemodynamic characteristics with MAP 73±18 versus 72±19 mm Hg (P=0.89), heart rate 78±17 versus 76±17/min (P=0.50), CVP 13±5 versus 13±5 mm Hg (P=0.99) in the TTM33 compared with TTM36, respectively. There was no difference in lactate levels (5.2±4.3 versus 5.1±4.1 mmol/L; P=0.83) in TTM33 compared with TTM36 group, respectively. First invasive measurements after insertion of pulmonary catheter are shown in Table 3 , and baseline transthoracic echocardiographic findings are shown in Table 4 .
Invasive Hemodynamics and Metabolism During Intervention
After 24 hours of TTM, the TTM33 group had a significant increase in SVRI compared with TTM36 (2595; 95% confidence interval, 2422-2767) versus 1960 (95% confidence interval, 1787-2134) dynes m 2 /s per cm 5 ; P<0.0001, respectively) with an overall difference in SVRI of β=556 (95% confidence limit [CL], 378-733) dynes m 2 /s per cm 5 (P group <0.0001; Figure 2 ). No interactions were found between temperature allocation and age, sex, initial rhythm, witnessed arrest, bystander cardiopulmonary resuscitation, and time to return of spontaneous circulation in regard of the effect on SVRI after 24 hours of TTM. The TTM33 group had a significantly lower CI (β=−0.4; 95% CL, −0.6 to −0.3 L/min per m 2 ; P group <0.0001), lower heart rate (β=−5.3; 95% CL, −9.4 to −1.1/min; P group =0.01), and lower stroke volume index (β=−4.4; 95% CL, −7.4 to 1.5 mL; P group =0.004) compared with the TTM36 group ( Table 3 ).
The linear relationship with all measurements of SVO 2 and CI <48 hours in the 2 TTM groups is depicted in Figure 3 with an overall significant positive correlation (P<0.0001; r=0.44). The observed correlation of SVO 2 and CI in the TTM33 group (P<0.0001; r=0.43) was weaker compared with the correlation coefficient in the TTM36 group (P<0.0001; r=0.47), but the differences in correlation were not statistically different (P interaction =0.21). After 24 hours of TTM, the correlation of SVO 2 and CI in the TTM33 group (P=0.01; r=0.29) was weaker, but not significantly different compared with the TTM36 group (P<0.0001; r=0.55; P interaction =0.06).
From randomization to 48 hours after return of spontaneous circulation, there were no overall differences in MAP (β=1.4 mm Hg; P group =0.20), CVP (β=−0.03 mm Hg; P group =0.96), or SVO 2 (β=−0.6; 95% CL, −2.3 to 1.1; P group =0.47) between the TTM33 and TTM36 groups, respectively. Data are presented as mean±SD or median and lower to upper quartile (Q1-Q3) as appropriate. The P value represents comparison between groups (TTM33 and TTM36). COPD indicates chronic obstructive pulmonary disease; CPR, cardiopulmonary resuscitation; IHD, ischemic heart disease; ROSC, return of spontaneously circulation; TTM33, targeted temperature management at 33°C; and TTM36, targeted temperature management at 36°C. Data regarding temperature, heart rate, MAP, lactate, propofol, and fentanyl are reported from the total population. Data regarding propofol and fentanyl are reported in the first 36 h where sedation was mandated. Data are presented as mean±SD or median and lower and upper quartile (Q1-Q3) as appropriate. Overall differences between TTM groups were evaluated with repeated-measures mixed models (P group). Differences at each time point were assessed by repeated-measures mixed models including the interaction term of TTM group with time. Statistical significance level of P<0.05. CI indicates cardiac index; CPI; cardiac power index; CVI, cumulative vasopressor index; CVP, central venous pressure; MAP, mean arterial pressure; mPAP, mean pulmonary arterial pressure; PAC, pulmonary artery catheter; PCWP, pulmonary capillary wedge pressure; PVRI, pulmonary vascular resistance index; SVI, stroke volume index; SVRI, systemic vascular resistance index; TTM33, targeted temperature management at 33°C; and TTM36, targeted temperature management at 36°C. 
Myocardial Function During Intervention
LVEF was not different in the TTM33 group at any time points <48 hours with an overall difference of β=2% (95% CL, −2% to 6%; P group =0.39) compared with TTM36 (Table 4) . After 24 hours of TTM, s′ (P=0.13), E/e′ (P=0.43), and tricuspid annular plane systolic excursion (P=0.49) were not significantly different in the TTM33 group compared with the TTM36 group. Controlling for differences in heart rate between the 2 TTM groups did not affect s′ (P=0.37). However, both left and right ventricular systolic function improved in both TTM groups <48 hours as LVEF increased 4% (95% CL, 1-6%; P=0.046), s′ increased 1.2 cm/s (95% CL, 0.6-1.8; P=0.0005), Error bars represent standard deviation and * a significant interaction between TTM group and time in repeated-measures mixed models. P group represents the overall difference between the 2 TTM groups <48 h after randomization. PAC indicates pulmonary artery catheter; TTM33, targeted temperature management at 33°C; and TTM36, targeted temperature management at 36°C. 
Sedation and Vasopressor Support During Intervention
At target temperature, the TTM33 group received higher doses of propofol (421±177 versus 339±175 mg/h; P=0.005) and fentanyl (180±61 versus 159±63 μg/h; P=0.04) compared with the TTM36 group, respectively (Table 3) . Cisatracurium was administered as 1 or several boluses in 127 (75%) of the patients. Overall, the cumulative doses of propofol, fentanyl, and cisatracurium were similar in the TTM33 versus TTM36 groups within the first 48 hours (Figure 4) . The median cumulative vasopressor index in the population was 2 (2-3) with 53% versus 45% (P=0. Results from per-protocol analyses of invasive measurements were not different from the intention-to-treat analyses presented (data not shown).
Discussion
TTM after cardiac arrest at 33°C compared with 36°C for 24 hours when targeting a MAP >65 mm Hg is associated with (1) increased systemic and pulmonary vascular resistance, (2) decreased cardiac and lower heart rate, (3) no impact on echocardiographic markers of myocardial contractility or relaxation, (4) no difference in SVO 2 , but higher levels of lactate and impaired lactate clearance. The observed hemodynamic differences between the TTM groups disappeared after rewarming. These significant differences in hemodynamic and metabolic impact of different target temperatures may have important clinical importance when choosing the optimal TTM regimen.
Lowering blood temperature may induce vasoconstriction of both pulmonary and systemic arterioles because of a local effect of cold blood on the vasculature. 15, 16 The substantial increase in systemic vascular resistance may be the primary stimulus that causes cardiac output to decrease secondarily. However, a direct effect on the heart of lowering core temperature may also play a minor role as heart rate progressively decreased. Reduction in the rate of spontaneous repolarization of cardiac pacemaker cells as well as prolongation of myocardial action potentials have been proposed as plausible mechanisms. 17, 18 Our study confirmed that cardiac output was decreased by 20% to 25% in the TTM33 group, mainly because of a 15% to 20% reduction in heart rate, but our results also suggested a slight reduction in stroke volume. However, the effect of temperature on myocardial contractility is not fully elucidated, and previous results reported that myocardial contractility may vary according to heart rate. 19 Our results suggested that reduced myocardial contractility played a minor role in decreasing cardiac output as neither LVEF nor s′ as markers of myocardial contractility differed between TTM groups, and importantly adjustment for heart rate did not change these results. Improvement in systolic function with improved myocardial contractility with diastolic function being negatively affected during hypothermia has been reported in an animal model using conductance catheter. 20, 21 The temperature-related changes in systolic or diastolic function could not be confirmed by echocardiographic-derived parameters in this study; however, echocardiography may be less sensitive compared with invasive methods.
The increase in systemic vascular resistance in the TTM33 group was accompanied by an increase in MAP despite a progressive fall in cardiac output during first part of the intervention compared with TTM36. This confirms previous findings suggesting that inducing hypothermia reduces cardiac output and increases SVR because of vasoconstriction of arterioles, explaining why MAP often remains unaffected or slightly elevated. 5, 22, 23 Our protocol for targeting MAP (≥65 mm Hg) and CVP (10-15 mm Hg) are consistent with current guideline recommendations, but should be acknowledged when interpreting the results of the present study.
Lowering core temperature is accompanied by a lower metabolic rate that equals the lower cardiac output why the balance of supply and demands remains relatively constant. 24, 25 The observed changes may, therefore, represent some degree of physiological adaptation to the decreased metabolic demands during cooling. In clinical practice, SVO 2 reflects 2 major components of cardiovascular physiology: oxygen delivery and whole-body oxygen extraction. Lower metabolic state with less extraction of oxygen may translate into an increase of SVO 2 , whereas a decrease in oxygen delivery, including decreased cardiac output, lowers SVO 2 , if the demands remain unchanged. TTM33 was associated with significantly lower cardiac output measured by the thermodilution technique, but this was not reflected by decreased mixed venous saturation. Oxygen extraction as the second component of SVO 2 indicates that the metabolic demands at 33°C is lower compared with 36°C suggestive of a hypometabolic state. A recent porcine model in myocardial infarction supports this hypothesis because mixed venous saturation increased during hypothermia despite a progressive reduction in cardiac output, whereas mixed venous saturation decreased in normothermic controls. 26 This also implies that SVO 2 as a marker of cardiac output may not be as reliable at lower temperatures, corresponding to the weaker correlations between SVO 2 and CI seen in the TTM33 group. 27 However, overall levels of lactate were higher in the TTM33 group suggesting that the metabolic supply and demands may be slightly imbalanced at 33°C, but interestingly lactate concentrations remained elevated during rewarming. Multiple mechanisms may contribute to increased lactate during cooling as fat metabolism increases and lactate clearance may be impaired; the latter may partly be explained by reduced liver flow during cooling.
18,28
Limitations
This analysis only refers to patients with no or moderate transient shock because severe and sustained shocks were an exclusion criteria. This substudy was performed in consecutive patients recruited at a single center and may represent a select population of OHCA patients, because the proportion of patients with male sex, ST-elevation myocardial infarction, and ventricular fibrillation was higher compared with a general OHCA population. Level of vasopressor support was assessed with 2 different scoring systems, acknowledging that the sensitivity of these scores may be too low to detect small differences in need for vasopressor support.
Conclusions
TTM at 33°C compared with 36°C for 24 hours with a treatment goal of MAP >65 mm Hg is associated with a significant increase in systemic and pulmonary vascular resistance and lactate levels. Cardiac output decreased at 33°C mainly because of lower heart rate with myocardial contractility including LVEF being unaffected compared with 36°C. The observed hemodynamic changes between groups disappeared by rewarming to normothermia. Choosing a target temperature regimen with less impact on metabolism and cardiovascular function may be important for balancing the benefits and hazards of TTM in individual patients.
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